Qtron Investments’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.34M | Sell |
33,442
-1,117
| -3% | -$78.1K | 0.3% | 59 |
|
|
2025
Q1 | $2.54M | Buy |
34,559
+2,314
| +7% | +$170K | 0.38% | 42 |
|
|
2024
Q4 | $2.11M | Sell |
32,245
-966
| -3% | -$63.3K | 0.3% | 54 |
|
|
2024
Q3 | $2.59M | Sell |
33,211
-1,188
| -3% | -$92.6K | 0.35% | 46 |
|
|
2024
Q2 | $2.68M | Buy |
34,399
+1,793
| +5% | +$140K | 0.39% | 41 |
|
|
2024
Q1 | $2.21M | Buy |
32,606
+6,122
| +23% | +$415K | 0.31% | 56 |
|
|
2023
Q4 | $1.78M | Buy |
26,484
+2,140
| +9% | +$144K | 0.29% | 66 |
|
|
2023
Q3 | $1.65M | Sell |
24,344
-8,823
| -27% | -$597K | 0.31% | 64 |
|
|
2023
Q2 | $2.37M | Buy |
33,167
+4,213
| +15% | +$302K | 0.45% | 48 |
|
|
2023
Q1 | $2.01M | Buy |
28,954
+1,744
| +6% | +$121K | 0.41% | 51 |
|
|
2022
Q4 | $1.84M | Buy |
27,210
+4,070
| +18% | +$276K | 0.39% | 57 |
|
|
2022
Q3 | $1.27M | Buy |
23,140
+2,620
| +13% | +$144K | 0.32% | 72 |
|
|
2022
Q2 | $1.36M | Hold |
20,520
| – | – | 0.3% | 74 |
|
|
2022
Q1 | $1.36M | Sell |
20,520
-1,875
| -8% | -$124K | 0.3% | 79 |
|
|
2021
Q4 | $1.31M | Sell |
22,395
-27
| -0.1% | -$1.57K | 0.29% | 83 |
|
|
2021
Q3 | $1.35M | Buy |
22,422
+7,020
| +46% | +$422K | 0.36% | 60 |
|
|
2021
Q2 | $923K | Buy |
15,402
+5,581
| +57% | +$334K | 0.23% | 112 |
|
|
2021
Q1 | $488K | Sell |
9,821
-4,975
| -34% | -$247K | 0.14% | 199 |
|
|
2020
Q4 | $740K | Hold |
14,796
| – | – | 0.2% | 118 |
|
|
2020
Q3 | $811K | Hold |
14,796
| – | – | 0.28% | 77 |
|
|
2020
Q2 | $783K | Buy |
14,796
+1,505
| +11% | +$79.6K | 0.31% | 77 |
|
|
2020
Q1 | $594K | Buy |
13,291
+8,733
| +192% | +$390K | 0.36% | 88 |
|
|
2019
Q4 | $227K | Buy |
+4,558
| New | +$227K | 0.13% | 200 |
|